Wednesday, February 10, 2010, 12:28am EST - Canadian Markets open in 9 hours and 2 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Micrus Endovascular Corp. (MEND)

On Feb 9: 18.60 USD  Up 0.73 (4.09%)  
MORE ON MEND
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Micrus Endovascular Corporation (NGM:MEND) Delayed quote dataEdit
After Hours: 18.60 0.00 (0.00%) as of 4:34pm EST on 02/09/10
Last Trade: 18.60 USD
Trade Time: Feb 9
Change: Up 0.73 (4.09%)
Prev Close: 17.87
Open: 17.99
Bid: 17.49 x 100
Ask: 19.67 x 200
1y Target Est: 21.45
Day's Range: 17.89 - 18.78
52wk Range: 4.13 - 18.78
Volume: 252,682
Avg Vol (3m): 93,071.4
Market Cap: 297.71M
P/E (ttm): 30.95
EPS (ttm): 0.60
Div & Yield: N/A (N/A%)
Micrus Endovascular Corp. (MEND)
1d  5d  3m  6m  1y  2y  5y 
 Add MEND to Portfolio   Download Data

HEADLINES
Micrus Endovascular (MEND): Zacks Rank Buy
Zacks.com (Mon, Feb 8)
New Star Analyst Rankings for Micrus Endovascular Corporation
StarMine (Sat, Feb 6)
MICRUS ENDOVASCULAR CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Feb 5)
Micrus Endovascular reports fiscal 3rd-qtr profit
AP (Thu, Feb 4)
Micrus moves from Q3 loss to $3.3M profit
at bizjournals.com (Thu, Feb 4)
MICRUS ENDOVASCULAR CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, Feb 4)
Micrus Endovascular Reports Fiscal Third Quarter Revenues of $22.8 Million and Diluted EPS of $0.20
Business Wire (Thu, Feb 4)
Micrus Endovascular to Hold Fiscal 2010 Third Quarter Conference Call on February 4
Business Wire (Thu, Jan 28)
Cashing In on Obamacare
at Motley Fool (Thu, Jan 21)
Helen of Troy Ltd. (HELE): Zacks Rank Buy
Zacks.com (Mon, Jan 18)
Zacks Releases Four Powerful ''Buy'' Stocks: Encore Capital Group, Inc., Harris Corp., Micrus Endovascular Corp. and Whirlpool Corporation
Zacks.com (Thu, Jan 14)
Micrus Endovascular Corp. (MEND): Zacks Rank Buy
Zacks.com (Thu, Jan 14)
Coverage initiated on Micrus Endovascular by Rodman & Renshaw
Briefing.com (Fri, Jan 8)
Micrus Endovascular to Present at January Investment Conferences
Business Wire (Tue, Jan 5)
More Headlines for MEND...

ANALYST
EPS Est (next year) (Mar-10) : 0.71
EPS Est (in 2 years) (Mar-11) : 0.76
Avg Rec (current)*: 1.6
PEG Ratio: 0.78
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Micrus Endovascular Corporation develops, manufactures, and markets implantable and disposable medical devices to treat cerebral vascular diseases. It offers MicruSphere Microcoil, a framing coil that stabilizes the aneurysm; Presidio Microcoil, a...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices